2017 Contraceptive Technology Boston

Mar 29, 2017 ‐ Apr 1, 2017


Issues you deal with every day in your practice are addressed in a variety of teaching styles including didactic sessions, faculty panels and interactive case study discussions. The conference discusses current research as well as recent and future developments in contraceptive technology. In addition, there are sessions that examine screening and clinical management of common and complex challenges in women’s health, including STIs, vaginitis, breast disease, chronic pelvic pain, menopause, abnormal vaginal bleeding as well as topics on developing strategies for providing care to LGBTQ patients, including screening and hormonal management.

Total CE Credits:

77.50 - Physician

77.50 - RN / NP (All RNs/Nurses except CA RNs)

77.50 - CA RN/CA BRN

22.75 - Pharmacology

38.50 - Pharmacist

Program Manager:

Donna Brian PhD, CRNP
Consultant
Contemporary Forums

Disclosures: The Program Manager has nothing to disclose

Standard: $930.00

Sessions

STI State of the Union: Drug Resistance and Disease Trends (Rx = .5 hr.)

Mar 29, 2017 8:00am ‐ Mar 29, 2017 8:30am
Expiration Date: Apr 25, 2020

Identification: PCA800

Credits: None available.

Learning Objectives:

  • Identify 3 emerging trends in STIs in the United States.
  • Describe 2 important STD prevention priorities for providers in varied health care settings.
  • Discuss 2 emerging concerns in the management of STIs an era of increasing antimicrobial resistance.


ACPE Numbers and CE Hours:

0263-000-17-683-L01-P (.5 contact hr.)

Speaker(s):
Standard: $12.00

Are All Progestins Equal? (Rx = .5 hr.)

Mar 29, 2017 8:00am ‐ Mar 29, 2017 8:30am
Expiration Date: Apr 25, 2020

Identification: PCC800

Credits: None available.

Learning Objectives:

  • Discuss the history and progression of synthetic progestins along with their pharmacokinetic properties
  • Review the evidence behind the FDA warning added to Drospirenone for a possible increase in the risk of clots
  • Discuss whether or not there are therapeutic differences seen with the progestins that could impact clinical decisions


ACPE Number and CE Hours:

0263-000-17-693-L01-P (.5 contact hr.)

Speaker(s): Disclosures
  • Ganesh Cherala, BPharm, PhD:

    Novo Nordisk Research Center

    Full-time Employee

Standard: $12.00

Update on Vaginitis: Taking Charge of Discharge (Rx = .75 hr.)

Mar 29, 2017 8:30am ‐ Mar 29, 2017 9:15am
Expiration Date: Apr 25, 2020

Identification: PCA830

Credits: None available.

Learning Objectives:

  • Discuss treatment options for common causes of vaginitis
  • Identify appropriate diagnostic testing strategies for vulvovaginal complaints
  • Describe strengths and weaknesses of the data on use of probiotics for vulvovaginal complaints

ACPE Number and CE Hours:

0263-000-17-684-L01-P (.75 contact hr.)

Speaker(s): Disclosures
  • Caroline Mitchell, MD, MPH:

    Symbionix Therapeutics, Perrigo Pharmaceuticals, Exeltis

    Consultant

Standard: $15.00

Risk of Clot or Not? Pill, Patch and Ring and VTE Risk (Rx = .75 hr.)

Mar 29, 2017 8:30am ‐ Mar 29, 2017 9:15am
Expiration Date: Apr 25, 2020

Identification: PCC830

Credits: None available.

Learning Objectives:

  • Review VTE risk and contraceptive steroid hormones
  • Discuss what is currently known regarding pill, patch, ring and VTE risk
  • identify contraceptive options for women at increased risk for VTE or who are currently anticoagulated

ACPE Number and CE Hours:

0263-000-17-694-L01-P (.75 contact hr.)

Speaker(s):
Standard: $15.00

Genital Herpes: New Developments and Strategies for Management and Prevention (Rx = .75 hr.)

Mar 29, 2017 9:15am ‐ Mar 29, 2017 10:00am
Expiration Date: Apr 25, 2020

Identification: PCA915

Credits: None available.

Learning Objectives:

  • Discuss the standard of care in genital herpes prevention, treatment, and suppression
  • Describe new therapeutics in the discovery pipeline for treatment of genital herpes
  • Describe novel strategies for prevention of genital herpes

ACPE Number and CE Hours:

0263-000-17-685-L01-P (.75 contact hr.)

Speaker(s): Disclosures
  • Nicholas Van Wagoner, MD, PhD, FACP:

    Genocea Biosciences

    Research (Site PI) Consultant

Standard: $15.00

Art vs. Science: Choosing the Right Pill, Patch, or Ring (Rx = .75 hr.)

Mar 29, 2017 9:15am ‐ Mar 29, 2017 10:00am
Expiration Date: Apr 25, 2020

Identification: PCC915

Credits: None available.

Learning Objectives:

  • Provide a head-to-head comparison regarding the differences in side effects regarding pills, patch, ring
  • Identify an algorithm in how to prescribe/choose a method - all things being equal
  • Review evidence regarding pregnancy ambivalence and methods to aid in shared decision making

ACPE Number and CE Hours:

0263-000-17-695-L01-P (.75 contact hr.)

Speaker(s):
Standard: $15.00

From A to Zika: Emerging Sexually Transmitted Infections (Rx = .25 hr.)

Mar 29, 2017 10:15am ‐ Mar 29, 2017 11:00am
Expiration Date: Apr 25, 2020

Identification: PCA1015

Credits: None available.

Learning Objectives:

  • Review latest data on sexual transmission of Neisseria meningitidis and Zika virus.
  • Distill prevention messages for patients to prevent sexual transmission of Neisseria meningitidis and Zika virus.

ACPE Number and CE Hours:

0263-000-17-686-L01-P (.75 contact hr.)

Speaker(s):
Standard: $15.00

Missed Patch, Pill, Ring? When to Worry and What to Do (Rx = .75 hr.)

Mar 29, 2017 10:15am ‐ Mar 29, 2017 11:00am
Expiration Date: Apr 25, 2020

Identification: PCC1015

Credits: None available.

Learning Objectives:

  • Review current guidance regarding counseling for missed or late method.
  • Review known evidence regarding pregnancy risk with a missed or late method.
  • Review evidence regarding methods to improve adherence.

ACPE Number and CE hours:

0263-000-17-696-L01-P (.75 contact hr.)

Speaker(s):
Standard: $15.00

STI Clinical Pearls: Challenging Cases (Rx = .75 hr.) - Faculty Panel - Q&D (Rx = .25 hr.) - Faculty Panel

Mar 29, 2017 11:00am ‐ Mar 29, 2017 12:15pm
Expiration Date: Apr 25, 2020

Identification: PCA1100

Credits: None available.

Learning Objectives:

We do not provide objectives for this session

ACPE Number and CE Hours:

0263-000-17-687-L01-P (1.25 contact hr.)

Standard: $21.00

The Daunting Downside of Three Marvelous Methods: Pills, Injections, and Condoms (Rx = .75 hr.) - Q&D (Rx = .25 hr.) - Faculty Panel

Mar 29, 2017 11:00am ‐ Mar 29, 2017 12:15pm
Expiration Date: Apr 25, 2020

Identification: PCC1100

Credits: None available.

Learning Objectives:

  • Women using condoms, pills or patches are many times more likely to become pregnant than woman using an IUD or an implant.
  • The most important reasons condoms are NOT used is that they are not on hand when needed and couples think they are "not at risk" even if they do have a condom available.
  • Depo-Provera users have the lowest continuation rates of any reversible contraceptive.

ACPE Number and CE Hours:

0263-000-17-697-L01-P (1.25 contact hr.)

Speaker(s):
Standard: $21.00